GEMINI-Supported Research is sponsored by Torrey Coast Foundation. The Gastroesophageal Malignancies Investigator Network Initiative (GEMINI), funded by the Torrey Coast Foundation, supports high-risk, high-reward preclinical research and Phase 1 investigator-initiated trials for gastric and esophageal cancers. The program emphasizes translational research that can move findings from the lab into clinical application, often supporting unconventional approaches or new investigators who may have difficulty securing funding from other sources. Geographic focus: National and International (U.S., Asia, Europe) Focus areas: Gastroesophageal Cancer, Preclinical Research, Phase 1 Clinical Trials, Translational Research, Gastric Cancer, Esophageal Cancer

NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.